How to Identify the Right Doctors Using CPT, ICD-10, and Claims Data: A Practical Guide for MedTech and Life Sciences Teams

Finding the right healthcare providers to target sounds straightforward until a commercial team actually tries to do it. In theory, you define a specialty, pull a list of physicians in the right geography, and assign reps to call on them. In practice, that workflow often produces bloated target lists, wasted outreach, and poor conversion. A specialty label alone rarely tells you whether a provider is actually performing the procedures tied to your product, treating the right patient population, or operating in a care setting where adoption is realistic.

That is why more life sciences, medtech, diagnostics, and digital health teams are moving away from static physician lists and toward claims-based provider targeting. Instead of asking only who a provider is, they ask what that provider is actually doing. That shift matters because the difference between a high-propensity account and a low-value one usually shows up in real-world activity, not in a directory field. CPT codes describe what services and procedures are being performed, while ICD-10-CM codes classify diagnoses and medical conditions. Together, they create a far more useful picture of provider relevance than specialty alone. The American Medical Association describes CPT as the code set used to describe medical services and procedures, while CDC and CMS describe ICD-10-CM as the standardized system used to code and classify diagnoses.

For commercial teams, this has immediate practical value. If you sell a GI diagnostic, an endoscopy device, a cardiology workflow tool, or a digital health solution for chronic disease management, you do not simply need “gastroenterologists,” “cardiologists,” or “primary care doctors.” You need the providers who are actively seeing the relevant patients, billing the relevant procedures, and working in settings that match your go-to-market model. That is the core promise of healthcare provider targeting using CPT codes, ICD-10 diagnosis data, and claims analytics.

Why Traditional Physician Targeting Often Fails

Many organizations still build target lists the old way. They start with specialty, add a region, maybe layer in health system affiliation, and then send reps or marketers out into the market. The problem is that this method confuses category membership with commercial relevance. A physician can have the “right” specialty and still be the wrong target because they do not perform the procedures tied to your product, do not see enough of the right patients, or work in a setting where your offering is not likely to be adopted.

Take a medical device company selling a product used primarily in ambulatory surgery centers for GI procedures. A broad list of gastroenterologists in a metropolitan area might look promising on paper, but in practice it will include physicians who mainly work in inpatient settings, physicians with low relevant procedural volume, and physicians whose case mix is poorly aligned to the company’s indication. A rep can spend weeks working through that list and still learn less than they would from a narrower, better-constructed cohort built from claims activity.

The same issue shows up in diagnostics and digital health. A molecular diagnostics company may want oncologists, but not every oncologist is equally relevant. A digital health company may want primary care, but not every primary care physician treats the target condition at a volume that supports strong adoption. This is where claims data changes the quality of targeting. Rather than assuming relevance, you can measure it.

Further reading on this:
The Role of Data in Targeting the Right Healthcare Providers, How CPT and HCPCS Data Unlocks Precision Targeting for Specialty Diagnostic Labs, and The Complete Healthcare Provider Data Platform Guide for Pharma and MedTech Teams. These pieces all reinforce the same fundamental truth: the most valuable provider intelligence comes from behavioral data, not just provider directories.

What CPT Codes Actually Tell You

CPT codes are especially valuable because they describe services and procedures performed by physicians and other qualified healthcare professionals. In a commercial context, that means CPT data gives you a practical signal of what providers are doing in the real world, not just what they are licensed or trained to do. The AMA notes that CPT primarily describes medical services and procedures, and CMS likewise uses CPT in reporting and reimbursement workflows.

If you sell a product related to colonoscopy, an account list built around the relevant lower GI CPT codes will be much more precise than a general “GI doctor” list. If you work in orthopedics, cardiology, wound care, women’s health, oncology, anesthesia, or neurology, the same principle holds. Procedure codes let you identify providers whose clinical activity aligns with your product. That is why searches like “how to use CPT codes for medical sales targeting” and “find doctors by procedure volume” are increasingly valuable commercial questions, not just coding questions.

CPT data is also useful because it supports relative prioritization. You are not limited to identifying whether a provider has ever billed a procedure. You can often use volume thresholds, recency, and related activity to separate occasional users from true high-volume targets. That lets commercial teams distinguish between “technically relevant” and “commercially meaningful.”

Further reading on this:
ICD-10 vs CPT vs HCPCS Codes: A Complete Beginner’s Guide for Healthcare & Life Science Marketing.

What ICD-10 Diagnosis Data Adds

CPT codes tell you what happened procedurally. ICD-10 diagnosis data tells you what kinds of patients and clinical problems are driving those encounters. CDC describes ICD-10-CM as the standardized system used to code diseases and medical conditions, and CMS notes that ICD-10 is the code framework used for diagnoses and inpatient procedures across HIPAA-covered entities.

This matters because procedure data alone can still leave blind spots. A provider may bill a given procedure, but if the underlying diagnosis mix is not aligned with your product’s intended use, that provider may still not be the best target. Conversely, a provider may have exactly the right patient population but relatively low procedural activity today, which could make them an ideal education or growth target.

For example, imagine a digital health company focused on patients with type 2 diabetes. If it only targets endocrinologists by specialty, it may miss high-value primary care physicians or internal medicine groups managing a large diabetic population. Diagnosis data allows the company to identify providers and organizations where the actual disease burden aligns with its solution. In another case, a medtech company may want providers treating high volumes of GERD, IBS, chronic heart failure, COPD, or migraine, depending on the product. ICD-10 data helps narrow the market to providers whose clinical reality matches the company’s commercial thesis.

Further reading on this:

How Specialty Labs Find the Exactly Right Doctors Using Diagnosis Data Diagnosis data is not just a reimbursement artifact; it is a practical tool for high-precision market segmentation.

Why CPT and ICD-10 Are Most Powerful Together

The real advantage appears when you combine procedural data and diagnosis data rather than treating them as separate lenses. A provider who bills a relevant procedure and treats the right patient population is generally more valuable than a provider who only satisfies one of those two conditions. This combination lets teams move from generic targeting to behavior-based provider segmentation.

A simple way to think about it is that CPT data tells you whether a provider’s workflow intersects with your product, while ICD-10 data tells you whether the provider’s patient population strengthens that fit. If your product is procedural, the CPT layer may carry more weight. If your product is diagnosis-driven, the ICD-10 layer may be more important. In most real commercial settings, both are necessary.

This is similar to evaluating a retail location. Foot traffic alone does not tell you enough, and demographics alone do not tell you enough. But when you know both who is coming through the door and what they are there to buy, you can make a much better decision. Healthcare provider targeting works the same way.

A Step-by-Step Framework for Finding the Right Doctors

A useful provider targeting workflow begins with clarity on the commercial use case. Before you pull codes or build lists, define what success looks like. Are you trying to find doctors for medical device sales, identify new accounts for specialty diagnostics, prioritize physicians for a digital health pilot, or support clinical-commercial alignment around a therapeutic area? The answer determines which signals matter most.

Once that is defined, the next step is mapping the use case to the right CPT, HCPCS, and ICD-10 signals. For some products, the procedure layer is dominant. For others, the diagnosis layer is dominant. If you sell a specialty diagnostic related to GI disease, for example, you might map the relevant colonoscopy or endoscopy procedure codes, then layer in diagnosis codes such as IBS, dyspepsia, GERD, inflammatory bowel disease, or other relevant GI conditions depending on the market. If you sell a remote monitoring solution, you may care about the RPM billing codes plus the chronic diagnosis profile of the provider.

The third step is narrowing by care setting. CMS maintains place-of-service codes that indicate where services were rendered, and those codes can help distinguish between inpatient, outpatient, office, home, and other care contexts. That is commercially useful because many products are far more likely to be adopted in one setting than another. If your product is mainly used in ambulatory surgery centers or office-based specialty practice, you do not want a target list dominated by providers whose relevant activity is mostly elsewhere.

The fourth step is ranking by volume, recency, and concentration. Not every relevant provider should be treated equally. Some will be high-volume users. Some will be emerging users. Some will be small but strategically important because of system influence, teaching status, referral patterns, or KOL value. This is where a robust provider data platform becomes essential.

Finally, the list should be validated in organizational context. In healthcare, a provider rarely acts in isolation. Health system affiliation, site-of-care mix, ownership changes, and network relationships can all affect access and adoption.

Further reading on this: How Unified Provider Data Drives Life Sciences

Example: How a MedTech Team Might Use This in Practice

Imagine a medtech company selling a GI-related device used primarily in outpatient and ambulatory settings. A rep team in a large U.S. territory needs to build a list of physicians most likely to be high-value targets. A weak method would start with all gastroenterologists in the territory. A much better method would identify the relevant lower and upper GI procedure codes, then isolate providers with meaningful claims activity tied to those codes. The team could then layer in diagnosis data to identify clinicians treating high volumes of the patient populations most relevant to the product. From there, they could refine the list using place-of-service context and organizational affiliation so that the resulting call plan reflects both clinical relevance and field execution realities.

The practical result is a shorter, sharper target list. That means fewer wasted calls, better territory coverage, more relevant messaging, and stronger conversion probability.

Further reading on this:
Unlocking MedTech Growth with CPT and HCPCS Claims Data: Smarter Physician Targeting and Market Expansion.

How This Improves Sales, Marketing, and Strategy

The immediate sales benefit is obvious: field teams can prioritize providers who are much more likely to be relevant. But the advantages go beyond sales routing. Marketing teams can build more precise physician audiences. Commercial operations can design territories around meaningful demand rather than legacy assumptions. Leadership teams can forecast opportunity more realistically. Product marketing can tailor messaging to provider cohorts based on what those providers actually do in practice.

This is why the question “how do I find doctors for medical sales?” is incomplete. The better question is “how do I find the right doctors for my product, my patient population, and my go-to-market motion?” Once you frame it that way, the importance of CPT codes, ICD-10 diagnosis data, claims data, provider identity resolution, and system context becomes much clearer.

Further reading on this:
Why Healthcare Growth Teams Are Moving Beyond Spreadsheets and Moving from Static Lists to Dynamic Provider Data. These articles illustrate the operational side of turning provider intelligence into scalable commercial workflows.

Final Thoughts

The best healthcare provider targeting strategies are no longer built on static lists and hopeful outreach. They are built on evidence. CPT codes help you understand what providers are doing. ICD-10 diagnosis data helps you understand which patient populations they are actually serving. Claims context helps you understand where care is happening. Organizational intelligence helps you understand how those providers fit into larger health systems and decision networks.

When these elements are unified, medtech, diagnostics, digital health, and life sciences teams can stop guessing which doctors matter and start building commercial strategies around real clinical behavior. That is the shift from generic medical sales leads to genuine healthcare provider intelligence.

Frequently Answered Questions

1. How do you find the right doctors for medical sales?

The most effective way to find the right doctors for medical sales is to move beyond specialty-only lists and use real-world provider activity data. In practice, that means combining CPT procedure data, ICD-10 diagnosis data, organizational affiliation, and territory context to identify providers whose clinical activity actually aligns with your product. A cardiology list, for example, is much less useful than a list of cardiologists and other providers actively treating the right cardiac population and performing the relevant procedures.

2. What is the difference between CPT and ICD-10 for provider targeting?

CPT codes primarily describe medical services and procedures, while ICD-10-CM codes classify diagnoses and medical conditions. In provider targeting, CPT helps answer what a provider is doing procedurally, while ICD-10 helps answer what kinds of patients that provider is seeing. The strongest targeting models usually use both.

3. Why is claims data useful for physician targeting?

Claims data is useful because it reflects real-world healthcare activity rather than static provider attributes. Instead of assuming relevance based on specialty or title, claims data lets commercial teams identify which providers are actually billing relevant procedures, treating relevant diagnoses, and operating in the most commercially relevant care settings.

4. Can CPT codes help identify high-volume providers?

Yes. CPT data can often be used not only to identify whether a provider has ever performed a relevant service, but also to estimate relative volume and concentration. That allows teams to rank providers by likely relevance and distinguish occasional users from consistently active, high-value targets. The exact approach depends on data source and aggregation method, but the principle is one of the most useful applications of claims-based targeting.

5. Do I need place-of-service data when targeting doctors?

Often, yes. Place-of-service context can be very important because the same provider may deliver relevant care in different settings, and not all settings are equally relevant for every product. CMS maintains place-of-service codes precisely to indicate where a service was provided, and that context can help commercial teams better match provider activity to their route-to-market.

6. What kinds of companies benefit most from this approach?

This approach is especially useful for medtech companies, digital health companies, specialty diagnostics, pharma commercial teams, market access teams, and organizations involved in provider segmentation, KOL identification, or territory planning. In any business where provider behavior matters more than provider title, claims-based targeting can materially improve commercial execution.

7. What is the best way to turn provider intelligence into field execution?

The best workflow is to first identify the right providers using claims and diagnosis data, then operationalize that intelligence through territory planning, CRM enrichment, route design, and account prioritization. Alpha Sophia has written about this operational side in Effective Sales Territory Planning in Medical Devices and Route Optimization for Medical Sales Reps.